NDC 0781-3003-70
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0781-3003
- Requested NDC
- 0781-3003-70
- Package NDCs from labels
- 0781-3003-70
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0781-3003-70 | ML - Milliliter | 0781-3003 | c5bea606-8733-403f-9922-27e7cac36f13 | 1 | 2012-07-24 |
| 0781-3003-75 | ML - Milliliter | 0781-3003 | 05b8546b-a7c0-4026-a387-1c23686a3b14 | 1 | 2012-07-24 |
| 0781-3003-92 | ML - Milliliter | 0781-3003 | 733f9055-a903-4ed2-b48c-7d44cb248059 | 1 | 2012-07-24 |
| 0781-3003-95 | ML - Milliliter | 0781-3003 | a6c41535-8339-4e65-88d7-dcfa7adbfaed | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Trifluridine | TRIFLURIDINE | Sandoz Inc | abc1d07f-91ee-4421-bc9b-457d0ed41f4c | 2024-08-01 | Warnings, Adverse reactions | Sandoz Inc |
| CILOXAN | CIPROFLOXACIN HYDROCHLORIDE | Sandoz Inc | 09ca5374-2a16-4a95-91b3-70591d78254e | 2024-07-30 | Warnings, Adverse reactions | Sandoz Inc |
| Bromocriptine mesylate | BROMOCRIPTINE MESYLATE | Sandoz Inc | c43c300d-8aec-4020-984a-42c1a917c08f | 2024-06-30 | Warnings, Adverse reactions | Sandoz Inc |
| Flumazenil | FLUMAZENIL | Hikma Pharmaceuticals USA Inc. | 436f5616-9626-4b6a-9deb-2986444179d0 | 2024-06-21 | Boxed warning, Warnings, Adverse reactions | Flumazenil FLUMAZENIL |
| CIMERLI | RANIBIZUMAB-EQRN | Sandoz Inc | 4b383d74-4830-4587-95f7-c32a39268df7 | 2024-06-17 | Warnings, Adverse reactions | Sandoz Inc |
| Flumazenil | FLUMAZENIL | A-S Medication Solutions | 2190e8d0-d7ca-4f53-b243-0d2c31979aa8 | 2024-06-14 | Boxed warning, Warnings, Adverse reactions | Flumazenil FLUMAZENIL |
| Enoxaparin Sodium | ENOXAPARIN SODIUM | Sandoz Inc | 38f60bd8-b518-4098-a808-b8f5a3ae6a3a | 2024-06-06 | Boxed warning, Warnings, Adverse reactions | Sandoz Inc |
| Zolpidem tartrate | ZOLPIDEM TARTRATE | Sandoz Inc | b1b0085f-d9fe-430a-9bd5-607f607bf7e1 | 2024-06-03 | Boxed warning, Warnings, Adverse reactions | Sandoz Inc |
| Alprazolam | ALPRAZOLAM | Sandoz Inc | d9b0e228-17cf-40d7-b62e-5050311c571c | 2024-05-31 | Boxed warning, Warnings, Adverse reactions | Sandoz Inc |
| Focalin | DEXMETHYLPHENIDATE HYDROCHLORIDE | Sandoz Inc | 2016f5c2-95d2-4655-af65-c588c2bf5e6d | 2024-05-30 | Boxed warning, Warnings, Adverse reactions | Sandoz Inc |
| Timolol GFS | TIMOLOL MALEATE | Sandoz Inc | 72b0d0ec-832a-4c25-b845-2537ab506354 | 2024-05-28 | Warnings, Adverse reactions | Sandoz Inc |
| Ampicillin | AMPICILLIN SODIUM | Sandoz Inc | 5308ddfa-4a5b-4f7b-83ce-9d1b528e050d | 2024-05-09 | Warnings, Adverse reactions | Sandoz Inc |
| Rivastigmine | RIVASTIGMINE | Sandoz Inc | 92a58ebb-748d-49f4-bf11-ecbcf5424152 | 2024-05-08 | Warnings, Adverse reactions | Sandoz Inc |
| Exelon | RIVASTIGMINE | Sandoz Inc | b6ed6d15-116d-4596-92ce-3414574d7ba0 | 2024-05-08 | Warnings, Adverse reactions | Sandoz Inc |
| Ampicillin | AMPICILLIN SODIUM | Sandoz Inc | 6632a5bd-45f1-422f-80b0-46e5a628969a | 2024-05-08 | Warnings, Adverse reactions | Sandoz Inc |
| Ampicillin | AMPICILLIN SODIUM | Sandoz Inc | f77db491-31c4-4a7c-a114-0f3244c97090 | 2024-05-07 | Warnings, Adverse reactions | Sandoz Inc |
| Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE | Sandoz Inc | 288dafc4-fe6e-4891-832f-511022c87445 | 2024-04-24 | Boxed warning, Warnings, Adverse reactions | Sandoz Inc |
| Flumazenil | FLUMAZENIL | Hikma Pharmaceuticals USA Inc. | 442ed32b-b508-40cc-9915-ff05674566da | 2024-04-09 | Boxed warning, Warnings, Adverse reactions | Flumazenil FLUMAZENIL |
| Perphenazine | PERPHENAZINE | Sandoz Inc | fc32500c-cc42-4f85-9cee-88f983fcbc16 | 2024-03-25 | Boxed warning, Warnings, Adverse reactions | Sandoz Inc |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | Sandoz Inc | 239018ff-cec6-46de-ae9d-26c9ec034a32 | 2024-03-22 | Warnings, Adverse reactions | Sandoz Inc |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.